Osteopore: Replacement Prospectus for Renounceable Rights Issue
Filed with ASX · · 56 pages · English
Summary by 6ix AI
Osteopore Ltd. has issued a replacement prospectus for a renounceable rights issue aimed at raising funds through the offer of new shares to eligible shareholders. The offer includes a specific ratio of new shares for existing shares, along with free attaching options, and is intended to raise a significant amount before costs. Shareholders are advised to read the entire prospectus carefully and consult professional advisers before making investment decisions.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Osteopore
- Update to Replacement Prospectus for Entitlement Offer
- Osteopore secures Singapore and Vietnam market approvals
- Prospectus for Renounceable Rights Issue
- OSX Entitlement Offer to support growth
- Activities Update Qtr Ending December 2023 and Appendix 4C
Later from Osteopore
- Osteopore extends Bridging Loan maturity date
- Response to ASX Query Letter
- Reinstatement to Official Quotation
- Pause in Trading
- Trading Halt
Follow Osteopore into a list and get an email when it puts out news.
Follow Osteopore